Cargando…

CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma

Background: Cyclin B2 (CCNB2) is an important component of the cyclin pathway and plays a key role in the occurrence and development of cancer. However, the correlation between prognosis of low-grade glioma (LGG), CCNB2, and tumor infiltrating lymphocytes is not clear. Methods: The expression of CCN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dengfeng, Sun, Hongjiao, Li, Xiaohui, Wang, Gang, Yan, Guizhong, Ren, Haijun, Hou, Boru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2022
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799923/ https://www.ncbi.nlm.nih.gov/pubmed/34908101 http://dx.doi.org/10.1042/BSR20211939

Ejemplares similares

An in silico approach to the identification of diagnostic and prognostic markers in low-grade gliomas
por: Özbek, Melih, et al.
Publicado: (2023)

A pyroptosis gene-based prognostic model for predicting survival in low-grade glioma
por: Wang, Hua, et al.
Publicado: (2023)

Expression patterns and the prognostic value of the EMILIN/Multimerin family members in low-grade glioma
por: Zhao, Yonghui, et al.
Publicado: (2020)

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma
por: Xiao, Kai, et al.
Publicado: (2020)

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma
por: Chen, Yanming, et al.
Publicado: (2021)

Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma
por: Zhu, Jin, et al.
Publicado: (2019)

Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study
por: Liu, Jieting, et al.
Publicado: (2021)

Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower‐grade gliomas
por: Ji, Qiankun, et al.
Publicado: (2022)

Identification of differentially expressed key genes between glioblastoma and low-grade glioma by bioinformatics analysis
por: Xu, Yang, et al.
Publicado: (2019)

PPP1R81 correlates with the survival and cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

Mutation-derived, genomic instability-associated lncRNAs are prognostic markers in gliomas
por: Li, Shenglun, et al.
Publicado: (2023)

HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma
por: Chen, Yan, et al.
Publicado: (2023)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma
por: Ji, Baowei, et al.
Publicado: (2020)

NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas
por: Sun, Huaiyu, et al.
Publicado: (2020)

Expression profiles and prognostic significance of WNT family members in glioma via bioinformatic analysis
por: Xu, Anqi, et al.
Publicado: (2020)

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

Overexpression of RAB34 associates with tumor aggressiveness and immune infiltration in glioma
por: Hou, Peng, et al.
Publicado: (2022)

The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1
por: Wang, Juntong, et al.
Publicado: (2020)

Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis
por: Wang, Jingyun, et al.
Publicado: (2021)

Identification of a circRNA-miRNA-mRNA regulatory network for exploring novel therapeutic options for glioma
por: He, Yi, et al.
Publicado: (2021)

Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment
por: Zhu, Zhipeng, et al.
Publicado: (2021)

CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zou, Yiping, et al.
Publicado: (2020)

The landscape and prognostic value of tumor-infiltrating immune cells in gastric cancer
por: Li, Linhai, et al.
Publicado: (2019)

Circular RNA expression profile of lung squamous cell carcinoma: identification of potential biomarkers and therapeutic targets
por: Wang, Yawei, et al.
Publicado: (2020)

Characterization of the basic helix–loop–helix gene family and its tissue-differential expression in response to salt stress in poplar
por: Zhao, Kai, et al.
Publicado: (2018)

Gene signatures with predictive and prognostic survival values in human osteosarcoma
por: Qiu, Zhongpeng, et al.
Publicado: (2021)

Prognostic value of magnetic resonance imaging features in low-grade gliomas
por: Deng, Liang, et al.
Publicado: (2019)

Construction of an immune-related signature with prognostic value for colon cancer
por: Lv, Yunxia, et al.
Publicado: (2021)

METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas
por: Shu, Xin, et al.
Publicado: (2021)

Prognostic value of the S100 calcium-binding protein family members in hepatocellular carcinoma
por: Wei, Ran, et al.
Publicado: (2023)

Identification of a novel six‐gene signature with potential prognostic and therapeutic value in cervical cancer
por: Qu, Xinyu, et al.
Publicado: (2021)

Multiple myeloma with pathologically proven skull plasmacytoma after a mild head injury: Case report
por: Yang, Wenzhen, et al.
Publicado: (2018)

Overexpression of KIAA1199 is an independent prognostic marker in laryngeal squamous cell carcinoma
por: Huang, Meixiang, et al.
Publicado: (2020)

Identification of hub genes related to prognosis in glioma
por: Zhang, Delong, et al.
Publicado: (2020)

The relationship between PLOD1 expression level and glioma prognosis investigated using public databases
por: Tian, Lei, et al.
Publicado: (2021)

Immunoglobulin superfamily member 10 is a novel prognostic biomarker for breast cancer
por: Wang, Mengxue, et al.
Publicado: (2020)

Prognostic values of the core components of the mammalian circadian clock in prostate cancer
por: Yue, Wenchang, et al.
Publicado: (2021)

Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets
por: Dobbs Spendlove, Mauri, et al.
Publicado: (2023)

High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration
por: Wang, Hai yue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hnf4or7fqdfml5m3v5ec48vrs6